CAYLEY BURTIS: Open Payments
NPI 1043889553 · MARION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,328 in 70 payments from 10 companies in 2025. Trend: 2023 $823 · 2024 $657 · 2025 $1,328
Food & beverage: $1,300Education: $27
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $353 |
| ABBVIE INC. | 15 | $214 |
| Otsuka America Pharmaceutical, Inc. | 10 | $186 |
| Neurocrine BioSciences, Inc. | 8 | $159 |
| E.R. Squibb & Sons, L.L.C. | 6 | $148 |
| Vanda Pharmaceuticals Inc. | 4 | $81 |
| Janssen Pharmaceuticals, Inc | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: ARISTADA, VRAYLAR, INGREZZA, COBENFY, REXULTI, FANAPT, SPRAVATO, CAPLYTA.
Industry payments across IL — which companies pay providers there.
